Literature DB >> 8495120

Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.

D R Anderson1, L A Fernandez.   

Abstract

Indications for using standard anticoagulants, heparin and warfarin; the dosage and route of administration; the importance of monitoring therapy with reliable laboratory indices; and complications of therapy are discussed. Acetylsalicylic acid and ticlopidine can be used as antiplatelet agents. Because their effect on platelet function is not monitored clinically, their clinical indications are emphasized.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495120      PMCID: PMC2379733     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  25 in total

Review 1.  Optimal therapeutic range for oral anticoagulants.

Authors:  J Hirsh; L Poller; D Deykin; M Levine; J E Dalen
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

Review 2.  Use of anticoagulants during pregnancy.

Authors:  J S Ginsberg; J Hirsh
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

3.  The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer.

Authors:  A M Shojania; J Tetreault; G Turnbull
Journal:  Am J Clin Pathol       Date:  1988-01       Impact factor: 2.493

4.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.

Authors:  C S Landefeld; M W Rosenblatt; L Goldman
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

Review 6.  Warfarin-induced skin necrosis in 2 patients with protein S deficiency: successful reinstatement of warfarin therapy.

Authors:  D R Anderson; P Brill-Edwards; I Walker
Journal:  Haemostasis       Date:  1992

7.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.

Authors:  W K Hass; J D Easton; H P Adams; W Pryse-Phillips; B A Molony; S Anderson; B Kamm
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

8.  Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.

Authors:  A G Turpie; J Gunstensen; J Hirsh; H Nelson; M Gent
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

9.  Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

Authors:  A Gallus; J Jackaman; J Tillett; W Mills; A Wycherley
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

Review 10.  Heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Annu Rev Med       Date:  1989       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.